Blood Groups and Acute Leukemia: A Records Review Study
Looks at how ABO and Rh blood groups are distributed in people with acute leukemia.
Plain-language title generated from the registry record
Registry title: ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
Key facts
- Where
- Asyut, EgyptSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people newly diagnosed with acute leukemia (ALL or AML) between 2022 and 2025 who were treated at or referred to South Egypt Cancer Institute, Assiut University, and whose blood group is on record.
- Sex
- All sexes can join.
- Disease stage
- New (de-novo) acute leukemia, either ALL or AML, confirmed between 2022 and 2025.
- Earlier treatment
- People with a blood transfusion before diagnosis or before blood grouping cannot join.
- Biomarker or test result
- ABO and Rh blood group data must be available.
Main reasons for not taking part
- Missing or incomplete blood group data
- Other cancers
- Chronic illnesses affecting the whole body
- Blood transfusion before diagnosis or blood grouping
Read by machine on 9 November 2026.
Where in Egypt
- South Egypt Cancer Institute - Assiut UniversityAsyut, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assiut University
- Trial code
- NCT07108010
- Record updated
- 6 August 2025
- Original description
This retrospective observational study aims to evaluate the distribution of ABO and Rh blood groups among patients diagnosed with acute leukemia. By analyzing medical records from leukemia cases, the study seeks to identify any potential associations between blood group types and the occurrence of the disease.Read full original descriptionShow less
Evaluation of ABO and Rh Blood Group Frequencies in Acute Leukemia
This retrospective observational study aims to evaluate the distribution of ABO and Rh blood groups among patients diagnosed with acute leukemia. By analyzing medical records from leukemia cases, the study seeks to identify any potential associations between blood group types and the occurrence of the disease.
Inclusion: Patients diagnosed with de-novo acute leukemia (ALL or AML); Diagnosis confirmed between 2022 and 2025; ABO and Rh blood group data available; Patients treated at or referred to South Egypt Cancer Institute, Assiut University.
Exclusion: History of blood transfusion prior to diagnosis or blood grouping; Presence of other malignancies or chronic systemic illnesses; Incomplete or missing blood group data.